NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $172,580 | -1.5% | 23,837 | +1.1% | 0.00% | – |
| Q2 2023 | $175,259 | -90.8% | 23,588 | -87.2% | 0.00% | -100.0% |
| Q4 2022 | $1,897,184 | -44.0% | 184,551 | -0.9% | 0.00% | -50.0% |
| Q3 2022 | $3,388,000 | -72.1% | 186,149 | -21.1% | 0.00% | -66.7% |
| Q2 2022 | $12,132,000 | -30.7% | 235,885 | -0.7% | 0.01% | -14.3% |
| Q1 2022 | $17,501,000 | -79.9% | 237,612 | -61.0% | 0.01% | -77.4% |
| Q4 2021 | $87,055,000 | -60.8% | 608,484 | -43.3% | 0.03% | -63.1% |
| Q3 2021 | $222,350,000 | -4.8% | 1,072,548 | -2.5% | 0.08% | -5.6% |
| Q2 2021 | $233,469,000 | -1.4% | 1,099,662 | -15.8% | 0.09% | -7.3% |
| Q1 2021 | $236,684,000 | +66.0% | 1,305,410 | +2.1% | 0.10% | +60.0% |
| Q4 2020 | $142,542,000 | -41.5% | 1,278,289 | -43.1% | 0.06% | -49.2% |
| Q3 2020 | $243,535,000 | -44.9% | 2,247,671 | -25.5% | 0.12% | -48.2% |
| Q2 2020 | $441,756,000 | +1784.7% | 3,016,424 | +74.8% | 0.23% | +1325.0% |
| Q1 2020 | $23,439,000 | – | 1,726,025 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |